Kazem Khavazi
-
Iranian COVID-19 vaccine undergoes clinical test
Tehran, Feb 28, IRNA – Razi Institute COV-Pars coronavirus vaccine which is the first injected-inhaled recombinant corona protein undergoes clinical test by two volunteers receiving the first dose.
-
Razi COVID-19 vaccine to begin clinical trial: Minister
Tehran, Feb 27, IRNA – Iran's Minister of Agricultural Jihad said on Saturday that the first and second phases of clinical trial of Razi COVID-19 vaccine will begin tomorrow.
-
Iran’s Razi Covo-Pars vaccine complies with WHO instructions: Minister
Tehran, Feb 7, IRNA – Iran’s Razi Covo-Pars vaccine (first injectable-inhalable vaccine of COVID-19 recombinant protein) made by Razi Vaccine and Serum Research Institute (RVSRI) has been produced using World Health Organization’s instructions, said Iran’s Minister of Agriculture Kazem Khavazi on Sunday.